中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
16期
89-90
,共2页
早发型%硫酸镁%子痫前期%低分子肝素%丹参
早髮型%硫痠鎂%子癇前期%低分子肝素%丹參
조발형%류산미%자간전기%저분자간소%단삼
Early onset%Magnesium sulfate%Preeclampsia%Low molecular heparin%Salvia miltiorrhiza
目的：研究分析早发型子痫前期不同治疗方案的临床效果，以寻求最佳治疗方案。方法所选对象来源于该院2012年4月-2014年5月接收的87例早发型子痫前期患者，基于治疗方案的不同将其分为3组，即A组、B组以及C组，3组病例数均为29例，A组仅用硫酸镁治疗，B组联合硫酸镁和丹参治疗，C组联合硫酸镁、丹参以及低分子肝素治疗，观察比较3组患者治疗效果。结果A组和B组、C组比较，24 h PRO (24 h尿蛋白定量)明显要高；C组和A组、B组比较，APTT(活化部分凝血活酶时间)明显要高，差异有统计学意义，即P<0.05。 C组和A组、B新生儿存活率比较，前者明显高于后两者，同时C组患者孕周延长天数明显比A组、B组长，差异有统计学意义，即P<0.05。结论经该研究结果分析可知，在早发型子痫前期临床治疗中，联合应用硫酸镁、丹参以及低分子肝素予以治疗，安全有效，获得满意的效果，提高新生儿存活率。
目的：研究分析早髮型子癇前期不同治療方案的臨床效果，以尋求最佳治療方案。方法所選對象來源于該院2012年4月-2014年5月接收的87例早髮型子癇前期患者，基于治療方案的不同將其分為3組，即A組、B組以及C組，3組病例數均為29例，A組僅用硫痠鎂治療，B組聯閤硫痠鎂和丹參治療，C組聯閤硫痠鎂、丹參以及低分子肝素治療，觀察比較3組患者治療效果。結果A組和B組、C組比較，24 h PRO (24 h尿蛋白定量)明顯要高；C組和A組、B組比較，APTT(活化部分凝血活酶時間)明顯要高，差異有統計學意義，即P<0.05。 C組和A組、B新生兒存活率比較，前者明顯高于後兩者，同時C組患者孕週延長天數明顯比A組、B組長，差異有統計學意義，即P<0.05。結論經該研究結果分析可知，在早髮型子癇前期臨床治療中，聯閤應用硫痠鎂、丹參以及低分子肝素予以治療，安全有效，穫得滿意的效果，提高新生兒存活率。
목적：연구분석조발형자간전기불동치료방안적림상효과，이심구최가치료방안。방법소선대상래원우해원2012년4월-2014년5월접수적87례조발형자간전기환자，기우치료방안적불동장기분위3조，즉A조、B조이급C조，3조병례수균위29례，A조부용류산미치료，B조연합류산미화단삼치료，C조연합류산미、단삼이급저분자간소치료，관찰비교3조환자치료효과。결과A조화B조、C조비교，24 h PRO (24 h뇨단백정량)명현요고；C조화A조、B조비교，APTT(활화부분응혈활매시간)명현요고，차이유통계학의의，즉P<0.05。 C조화A조、B신생인존활솔비교，전자명현고우후량자，동시C조환자잉주연장천수명현비A조、B조장，차이유통계학의의，즉P<0.05。결론경해연구결과분석가지，재조발형자간전기림상치료중，연합응용류산미、단삼이급저분자간소여이치료，안전유효，획득만의적효과，제고신생인존활솔。
Objective To study the clinical effect of different treatments for early-onset preeclampsia and determines the optimum schem. Methods 87 patients with early-onset preeclampsia admitted to our hospital between April 2012 and May 2014 were se-lected as the objects and divided according to the different treatment into three groups, group A, group B, group C, 29 in each group. Patients in group A, group B, group C received magnesium sulfate treatment, magnesium sulfate and salvia miltiorrhiza therapy, magnesium sulfate, salvia miltiorrhiza, and low molecular heparin therapy, combined therapy of magnesium sulfate, salvia miltiorrhiza, and low molecular heparin observation, respectively. Effects of three groups were compared. Results In group A and group B and group C, 24 hour PRO (quantitative) 24 hours urinary protein significantly higher;Compared with group A and group B, group C APTT (activated clotting time live enzymes) significantly high, significant difference statistically significant, that is, P<0.05. Group C compared with group A and B neonatal survival, the former is significantly higher than the latter two, at the same time patients with gestational age to extend the number of days of group C compared with group A, B, significant difference was statistically significant, that is, P<0.05. Conclusion The study shows that combined therapy of magnesium sulfate, salvia miltior-rhiza, and low molecular heparin in the treatment of early-onset preeclampsia, is safe, effective and satisfying and it can improve the neonatal survival rate.
